Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries / Vol. 75 / No. 4, July 2, 2026

Details

• Alternative Title:
  Surveillance for Candida auris — United States, 2022–2024
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries
• Personal Author:
  Gold, Jeremy A. W. ; Baker, Anna D. ; Benedict, Kaitlin ; Forsberg, Kaitlin ; Laury, Jessica E. ; Ghai, Ria R. ; Rankin, Danielle A. ; Walters, Maroya Spalding ; Lockhart, Shawn R. ; Jones, Sophie ; Lyman, Meghan
• Corporate Authors:
  Centers for Disease Control (U.S.)
• Description:
  Candida auris is an emerging yeast that is frequently resistant to antifungal drugs. C. auris can cause invasive infections associated with high mortality and can colonize patients asymptomatically, which facilitates transmission in health care settings. Since it was first reported in the United States in 2016, C. auris has been identified in multiple states, with increasing numbers of cases reported annually. Monitoring national trends in cases identified through clinical testing and screening for colonization is critical to guide infection prevention and control efforts.
• Subjects:
  Antifungal Agents Candida Auris Delivery Of Health Care Saccharomyces Cerevisiae
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2026; v. 75, no.4
• Series:
  Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
• Document Type:
  Text
• Genre:
  Journal Issue
• Place as Subject:
  United States
• Pages in Document:
  14 pdf pages
• Volume:
  75
• Issue:
  4
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:03bb1431fc55751b5c6370d0189dd1d764d1e3eee53922f712bfa12a5f88c3cf2667fc3300285759daba31868deaa07096a48c2dc75f3bbcb3f0d95b9759cb02
• Download URL:
  https://stacks.cdc.gov/view/cdc/257654/cdc_257654_DS1.pdf
• File Type:
  [PDF - 350.55 KB ]